Clinical Pilot Study for Personalized Risk-based Breast Cancer Screening
NCT ID: NCT05731453
Last Updated: 2024-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
80 participants
INTERVENTIONAL
2023-02-01
2035-11-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Personalized Breast Cancer Screening
NCT06060938
Under- and Overdiagnosis in BreastScreen Norway
NCT03852953
Long-term Effects of Breast Cancer Treatment
NCT03877029
Women At Risk: The High Risk Breast Cancer Program
NCT01034891
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Polygenetic risk score
Assessment of polygenetic risk score for breast cancer
Polygenetic risk score
Polygenetic risk score assessment for breast cancer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Polygenetic risk score
Polygenetic risk score assessment for breast cancer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Breast density BI-RADS a or d
* 40-50 y.o.
Exclusion Criteria
* Prior genetic counselling/testing
40 Years
50 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Vestre Viken Hospital Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tone Hovda, Phd
Role: PRINCIPAL_INVESTIGATOR
Vestre Viken HT
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vestre Viken Hospital Trust
Drammen, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
494936
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.